Reference data : LOINC code

Filter


Clear filter

Results
108,248 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType <span class='defaultText'>DefinitionDescription</span> dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
98960-8 Dehydroaripiprazole PrThr Urine Pt Ord Confirm &nbsp; ACTIVE Dehydroaripiprazole [Presence] in Urine by Confirmatory method &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 98960-8 &nbsp; Confirm &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Dehydroaripiprazole Ur Ql Cfm &nbsp; &nbsp; &nbsp; N &nbsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
98961-6 Lurasidone PrThr Urine Pt Ord Confirm &nbsp; ACTIVE Lurasidone [Presence] in Urine by Confirmatory method &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 98961-6 &nbsp; Confirm &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Lurasidone Ur Ql Cfm &nbsp; &nbsp; &nbsp; N &nbsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Latuda; LC/MS/MS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
98962-4 Cariprazine PrThr Urine Pt Ord Confirm &nbsp; ACTIVE Cariprazine [Presence] in Urine by Confirmatory method &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 98962-4 &nbsp; Confirm &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Cariprazine Ur Ql Cfm &nbsp; &nbsp; &nbsp; N &nbsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RGH 188; Screen; UA; UR; Urn; Vraylar 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
98963-2 Cariprazine MCnc Urine Pt Qn Confirm &nbsp; ACTIVE Cariprazine [Mass/volume] in Urine by Confirmatory method &nbsp; ADD DefinitionDescription &nbsp; &nbsp; ng/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 98963-2 &nbsp; Confirm &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Cariprazine Ur Cfm-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; RGH 188; UA; UR; Urn; Vraylar 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ng/mL &nbsp; &nbsp; &nbsp; 0
98964-0 Brexpiprazole PrThr Urine Pt Ord Confirm &nbsp; ACTIVE Brexpiprazole [Presence] in Urine by Confirmatory method &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 98964-0 &nbsp; Confirm &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Brexpiprazole Ur Ql Cfm &nbsp; &nbsp; &nbsp; N &nbsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rexulti; Screen; UA; UR; Urn 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
98965-7 Brexpiprazole MCnc Urine Pt Qn Confirm &nbsp; ACTIVE Brexpiprazole [Mass/volume] in Urine by Confirmatory method &nbsp; ADD DefinitionDescription &nbsp; &nbsp; ng/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 98965-7 &nbsp; Confirm &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Brexpiprazole Ur Cfm-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rexulti; UA; UR; Urn 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ng/mL &nbsp; &nbsp; &nbsp; 0
98966-5 Antipsychotics drug panel - Urine Pt - Confirm &nbsp; ACTIVE Antipsychotics drug panel - Urine by Confirmatory method &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.DRUG/TOX &nbsp; 98966-5 &nbsp; Confirm &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 Antipsychotics Pnl Ur Cfm &nbsp; &nbsp; &nbsp; N &nbsp; Antipsychotic; Antipsychotics Pnl; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; neuroleptics; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; UA; UR; Urn 2.72 2.72 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
98967-3 Nutritional Risk Screening 2002 panel - ^Patient Pt - NRS_2002 &nbsp; ACTIVE Nutritional Risk Screening 2002 panel &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.CLIN.RISK &nbsp; 98967-3 &nbsp; NRS_2002 &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 NRS 2002 &nbsp; &nbsp; &nbsp; N &nbsp; Asympt; Asymptomatic; CLIN; CLIN.RISK; NRS 2002; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Random; Scn; SDOH 2.72 2.72 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
98968-1 Initial screening - ^Patient Pt - NRS_2002 &nbsp; ACTIVE Initial screening NRS_2002 &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.CLIN.RISK &nbsp; 98968-1 &nbsp; NRS_2002 &nbsp; &nbsp; Subset &nbsp; &nbsp; &nbsp; 0 Initial screening NRS_2002 &nbsp; &nbsp; &nbsp; N &nbsp; Asympt; Asymptomatic; CLIN; CLIN.RISK; Pan; Panel; PANEL.CLINICAL; Panl; Pnl; Point in time; Random; Scn 2.72 2.72 &nbsp; Organizer &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
98969-9 Lost weight in last 3Mo Find ^Patient 3Mo Ord &nbsp; &nbsp; ACTIVE Lost weight in last 3 months &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CLIN.RISK &nbsp; 98969-9 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Lost weight in last 3Mo &nbsp; &nbsp; &nbsp; N &nbsp; 3 months; CLIN; CLIN.RISK; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Wt 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
9897-0 P wave amplitude.lead V3 Elpot Heart Pt Qn EKG &nbsp; ACTIVE P wave amplitude in lead V3 &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; EKG.MEAS &nbsp; 9897-0 &nbsp; EKG &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 P wave Amp L-V3 &nbsp; &nbsp; &nbsp; Y &nbsp; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; P prime; P' wave Amp L-V3; P wave Amp L-V3; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; Voltage 2.48 1.0i &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; 0
98970-7 Reduced nutritional intake in last W Find ^Patient 1W Ord &nbsp; &nbsp; ACTIVE Reduced nutritional intake in last week in the past week &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CLIN.RISK &nbsp; 98970-7 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Reduced nutritio intake in last W &nbsp; &nbsp; &nbsp; N &nbsp; 1 week; CLIN; CLIN.RISK; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Reduced nutritio intake in last W; Screen 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
98971-5 Severely ill Find ^Patient Pt Ord &nbsp; &nbsp; ACTIVE Severely ill &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CLIN.RISK &nbsp; 98971-5 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Severely ill &nbsp; &nbsp; &nbsp; N &nbsp; CLIN; CLIN.RISK; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
98972-3 Final screening - ^Patient Pt - NRS_2002 &nbsp; ACTIVE Final screening NRS_2002 &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.CLIN.RISK &nbsp; 98972-3 &nbsp; NRS_2002 &nbsp; &nbsp; Subset &nbsp; &nbsp; &nbsp; 0 Final screening NRS_2002 &nbsp; &nbsp; &nbsp; N &nbsp; Asympt; Asymptomatic; CLIN; CLIN.RISK; Pan; Panel; PANEL.CLINICAL; Panl; Pnl; Point in time; Random; Scn 2.72 2.72 &nbsp; Organizer &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
98973-1 Impaired nutritional status Find ^Patient Pt Ord &nbsp; &nbsp; ACTIVE Impaired nutritional status &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; H&P.HX &nbsp; 98973-1 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Impaired nutrition status &nbsp; &nbsp; &nbsp; N &nbsp; Finding; Findings; H+P; H+P.HX; Impaired nutrition status; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
98974-9 Total score Score ^Patient Pt Qn NRS_2002 &nbsp; ACTIVE Total score NRS_2002 &nbsp; ADD DefinitionDescription &nbsp; &nbsp; score &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CLIN.RISK &nbsp; 98974-9 &nbsp; NRS_2002 &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Total score NRS_2002 &nbsp; &nbsp; &nbsp; N &nbsp; CLIN; CLIN.RISK; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Tot; Totl 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; {score} &nbsp; &nbsp; &nbsp; 0
98975-6 Children's HealthWatch Housing Stability Vital Sign - ^Patient RptPeriod - HSVS &nbsp; ACTIVE Children's HealthWatch Housing Stability Vital Sign [Housing Stability Vital Sign] &nbsp; PANEL DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; �© 2019 Children's HealthWatch, Boston Medical Center Used with permission. &nbsp; &nbsp; &nbsp; &nbsp; PANEL.SURVEY.SDOH &nbsp; 98975-6 &nbsp; HSVS &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; CHW HSVS; Pan; Panel; Panl; Pnl; Report period; S prime; SDOH; Survey 2.81 2.72 &nbsp; Panel &nbsp; &nbsp; �© 2019 Children's HealthWatch, Boston Medical Center Used with permission. &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
98976-4 Behind on rent or mortgage at any time Find ^Patient 12Mo Ord &nbsp; &nbsp; ACTIVE Behind on rent or mortgage at any time in past 12 months &nbsp; NAM DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.SDOH &nbsp; 98976-4 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; 1 year; 12Mos; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey 2.81 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
98977-2 Number of residential moves Num ^Patient 12Mo Qn &nbsp; &nbsp; ACTIVE Number of residential moves in past 12 months &nbsp; NAM DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.SDOH &nbsp; 98977-2 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; 1 year; 12Mos; Cnt; Count; No; Num; Number; QNT; Quan; Quant; Quantitative; Survey 2.81 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; /a &nbsp; &nbsp; &nbsp; 0
98978-0 Homeless or living in shelter at any time Find ^Patient 12Mo Ord &nbsp; &nbsp; ACTIVE Homeless or living in shelter at any time in past 12 months &nbsp; PANEL DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.SURVEY.SDOH &nbsp; 98978-0 &nbsp; &nbsp; &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; 1 year; 12Mos; Finding; Findings; Ordinal; Pan; Panel; Panl; Pnl; QL; Qual; Qualitative; Screen; Survey 2.81 2.72 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
98979-8 Glomerular filtration rate ArVRat Ser/Plas/Bld Pt Qn Creatinine-based formula (CKD-EPI 2021)/1.73 sq M &nbsp; ACTIVE Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M &nbsp; NAM DefinitionDescription &nbsp; &nbsp; mL/min/1.73 sq M &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 98979-8 &nbsp; Creatinine-based formula (CKD-EPI 2021)/1.73 sq M &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 eGFRcr SerPlBld CKD-EPI 2021 &nbsp; &nbsp; &nbsp; N &nbsp; Blood; Chemistry; GFR; Glom; Pl; PlasBld; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; Square Meter; SR; Volume rate/area; Volume Rate/Ratio; WB; Whole blood 2.79 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mL/min/{1.73_m2} &nbsp; &nbsp; Release 2.79: COMPONENT: Triggered by Coll w SCT: eGFR measurement representation in LOINC had changed in LOINC: Component: Glomerular filtration rate, and Method: .../1.73 sq.M among non-black population or �/1.73 sq.M among black population, and others�.; 0
9898-8 P wave amplitude.lead V4 Elpot Heart Pt Qn EKG &nbsp; ACTIVE P wave amplitude in lead V4 &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; EKG.MEAS &nbsp; 9898-8 &nbsp; EKG &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 P wave Amp L-V4 &nbsp; &nbsp; &nbsp; Y &nbsp; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; P prime; P' wave Amp L-V4; P wave Amp L-V4; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; Voltage 2.48 1.0i &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; 0
98980-6 Glomerular filtration rate ArVRat Ser/Plas/Bld Pt Qn Creatinine and Cystatin C-based formula (CKD-EPI 2021)/1.73 sq M &nbsp; ACTIVE Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine and Cystatin C-based formula (CKD-EPI 2021)/1.73 sq M &nbsp; NAM DefinitionDescription &nbsp; &nbsp; mL/min/1.73 sq M &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 98980-6 &nbsp; Creatinine and Cystatin C-based formula (CKD-EPI 2021)/1.73 sq M &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 eGFRcr-cys SerPlBld CKD-EPI 2021 &nbsp; &nbsp; &nbsp; N &nbsp; Blood; Chemistry; Creat+Cyst CKD-EPI; Creat+Cyst CKD-EPI 2021; GFR; Glom; Pl; PlasBld; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; Square Meter; SR; Volume rate/area; Volume Rate/Ratio; WB; Whole blood 2.79 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mL/min/{1.73_m2} &nbsp; &nbsp; Release 2.79: COMPONENT: Triggered by Coll w SCT: eGFR measurement representation in LOINC had changed in LOINC: Component: Glomerular filtration rate, and Method: .../1.73 sq.M among non-black population or �/1.73 sq.M among black population, and others�.; 0
98981-4 Urate MCnc Bld Pt Qn &nbsp; &nbsp; ACTIVE Urate [Mass/volume] in Blood &nbsp; ADD DefinitionDescription &nbsp; &nbsp; mg/dL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 98981-4 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Urate Bld-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; Blood; Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; Urates; Uric acid; WB; Whole blood 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mg/dL &nbsp; &nbsp; &nbsp; 0
98982-2 6-Hydroxybuspirone MCnc Urine Pt Qn Confirm &nbsp; ACTIVE 6-Hydroxybuspirone [Mass/volume] in Urine by Confirmatory method &nbsp; ADD DefinitionDescription &nbsp; &nbsp; ng/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 98982-2 &nbsp; Confirm &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 6OH-buspirone Ur Cfm-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; 6OH-buspirone; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ng/mL &nbsp; &nbsp; &nbsp; 0
108,248 results found